Astec LifeSciences Limited (ASTEC) — Board Meeting | 31 July 2026
The Board of Astec LifeSciences approved unaudited standalone and consolidated financial results for Q1 FY26 ending June 30, 2026, showing revenue of ₹8,427.28 lakhs and a net loss of ₹1,873.84 lakhs. The results were reviewed by auditors with an unmodified opinion, and the filing includes detailed financial statements and disclosures.
About Astec LifeSciences Limited (ASTEC)
Chemicals · Fertilizers & Agrochemicals · Listed on NSE
📡 Get AI alerts when ASTEC files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ASTEC — Free💡 Ask AI about this filing
📊 More ASTEC filings
- share transfer — 15 July 2026 Astec LifeSciences received a compliance certificate from its share transfer agent confirming adhere...
- 🔴 Annual Report — 8 July 2026 The Annual Report 2025-26 for Astec LifeSciences Limited (NSE: ASTEC) details FY2025-26 financial pe...
- 🔴 Annual Report — 8 July 2026 The 32nd Annual General Meeting of Astec LifeSciences Limited is scheduled for 31 July 2026 via vide...
- 🟡 Board Meeting — 4 July 2026 No summary available
- 🟡 Voting Results — 4 July 2026 The company announced the results of a postal ballot vote held on July 4, 2026, confirming the passa...
🔥 Also filed on 31 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ASTEC files new disclosures
Track ASTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ASTEC — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research